EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Quality indicators for selected types of cancers: a scoping review

Matías Libuy, Xaviera Molina, Óscar Arteaga, Paula Bedregal, Cristian Rebolledo, Marion Luan, Carolina de la Fuente, Victoria Lermanda, Pedro Zitko

IJQHC Communications · 2026-07-04 · 6 (2)

DOI: 10.1093/ijcoms/lyag043 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background Cancer is a leading cause of death in Chile, exposing persistent inequities and gaps in the quality and timeliness of care. Up-to-date, comparable quality indicators are essential to evaluate performance across the cancer care continuum. This scoping review identifies and classifies oncology quality indicators for high-prevalence cancers in Chile using Donabedian’s framework (structure, process, outcome) and Chiew’s care components (prevention, screening, diagnosis, staging, pre-treatment evaluation, treatment, follow-up). Methods Following the PRISMA-ScR guideline, we systematically searched 13 international databases and grey-literature sources between July 2023 and July 2024. Eligible records were studies or policy documents describing, validating, or applying oncology quality indicators for breast, cervical, prostate, gastric, colorectal, gallbladder, or lung cancer in English or Spanish (1990–2024). Two reviewers independently screened, extracted, deduplicated, and harmonized indicators using a pre-specified definition of indicator uniqueness. The protocol was registered in the Open Science Framework (DOI: 10.17605/OSF.IO/BQXYN). Results From 4200 records, 59 publications were included, yielding 707 unique indicators: 38 structure, 593 process, and 76 outcome. Most addressed treatment, while few covered prevention, screening, or follow-up. No quality indicators for gallbladder cancer were identified within the English- and Spanish-language literature searched—a major evidence gap for a tumour of high national burden. Heterogeneity of indicator definitions and lack of equity-sensitive measures limited cross-cancer comparability. Conclusion Quality measurement in oncology remains unbalanced: indicators are abundant for lung, breast, and colorectal cancers but scarce for gastric and cervical cancer, and none were retrieved for gallbladder cancer within the English- and Spanish-language literature searched. Standardized, equity-oriented indicators for underrepresented cancers are critical for monitoring and policy in Chile and similar middle-income settings. To strengthen the link between measurement and patient-level results, we recommend that core indicator sets explicitly pair each process indicator with at least one measurable downstream outcome.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →